Takeda, Eli Lilly Lose High Court Bid Over Actos RICO Claims
The U.S. Supreme Court on Monday declined to hear an appeal by Takeda Pharmaceutical Co. and Eli Lilly & Co. over a suit by patients and health benefit funds alleging the...To view the full article, register now.
Already a subscriber? Click here to view full article